Phenytoin and Membrane Fluidity in Myotonic Dystrophy
- 1 August 1975
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 32 (8) , 535-538
- https://doi.org/10.1001/archneur.1975.00490500055006
Abstract
Electron spin resonance spectroscopy was used to substantiate the presence of a membrane defect in myotonic erythrocytes. There was increased membrane fluidity and decreased polarity in myotonic membranes. Phenytoin (formerly diphenylhydantoin) "normalizes" fluidity differences in spectra derived from myotonic erythrocytes but has no significant effect on normal spectra. These experiments demonstrate the applicability of biophysical methods to human erythrocyte membranes and support the concept of a membrane defect in myotonic dystrophy that does not have a primary myopathic, neuropathic, or vascular cause.Keywords
This publication has 20 references indexed in Scilit:
- Muscle membrane protein kinase in myotonic muscular dystrophyNature, 1974
- Protein Kinase Activity in Erythrocyte Ghosts of Patients with Myotonic Muscular DystrophyProceedings of the National Academy of Sciences, 1973
- Electron Spin Resonance Studies of Spin-Labeled Mammalian Cells by Detection of Surface-Membrane SignalsProceedings of the National Academy of Sciences, 1973
- Diphenylhydantoin and Ion Flux in Lobster NerveArchives of Neurology, 1972
- Molecular motion in spin-labeled phospholipids and membranesJournal of the American Chemical Society, 1971
- MOTION OF STEROID SPIN LABELS IN MEMBRANESProceedings of the National Academy of Sciences, 1969
- Spin-label studies of the excitable membranes of nerve and muscle.Proceedings of the National Academy of Sciences, 1968
- The Essential Mechanism in MyotoniaNeurology, 1952
- THE PHENOMENON OF MYOTONIABrain, 1941
- AN ELECTROMYOGRAPHIC STUDY OF MYOTONIAArchives of Neurology & Psychiatry, 1936